Abstract

BackgroundChoice and pattern of use of biological therapies in rheumatoid arthritis (RA) depends on many factors. Distinct timing of availability in the market as well as of supportive scientific information...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call